(19)
(11) EP 4 798 702 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24805004.9

(22) Date of filing: 23.10.2024
(51) International Patent Classification (IPC): 
C12N 9/00(2006.01)
C12N 9/10(2006.01)
A61K 38/00(2006.01)
C07K 14/47(2006.01)
C12N 9/78(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/00; C12N 9/93; G01N 2333/9015; C12Y 305/04004; C12Y 603/02019; C07K 14/4702; C12N 9/10; C12N 9/78; C07K 14/4747; C07K 14/4738; C07K 14/47
(86) International application number:
PCT/US2024/052569
(87) International publication number:
WO 2025/090610 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 26.10.2023 US 202363545875 P

(71) Applicant: TRIANA Biomedicines, Inc.
Lexington, MA 02421 (US)

(72) Inventors:
  • BART, Aaron
    Lexington, MA 02421 (US)
  • KAMADURAI, Hari
    Lexington, MA 02421 (US)
  • MARCOUX, David
    Lexington, MA 02421 (US)
  • LA, Daniel
    Lexington, MA 02421 (US)
  • CONERY, Andrew, Ryan
    Belmont, MA 02478 (US)
  • MEDIKONDA, Aravind, Prasad
    Lexington, MA 02421 (US)
  • TROJER, Patrick
    Waltham, MA 02451 (US)
  • SEYB, Kathleen
    Waltham, MA 02451 (US)
  • WIGLE, Timothy
    Waltham, MA 02451 (US)

(74) Representative: Potter Clarkson 
Chapel Quarter Mount Street
Nottingham NG1 6HQ
Nottingham NG1 6HQ (GB)

   


(54) TARGETED PROTEIN DEGRADATION